PrabotulinumtoxinA-xvfs for the Treatment of Moderate-to-Severe Glabellar Lines
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Pharmacotherapy"
DOI: 10.1177/1060028020943527
Abstract: Objective PrabotulinumtoxinA-xvfs (Jeuveau), a botulinum toxin type A, was approved by the Food and Drug Administration for the temporary improvement in the appearance of moderate-to-severe glabellar lines in February 2019. This article will review phase… read more here.
Keywords: severe glabellar; prabotulinumtoxina; prabotulinumtoxina xvfs; glabellar lines ... See more keywords